Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures
Divya Asher, Stewart J. Tepper, Merle L. Diamond, Joe Hirman et al.
Citations
3 citations
Journal
Journal of Neurology
Topics
Migraine and Headache Studies
Field-Weighted Citation Impact (FWCI)
1.16
article
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures
Divya Asher, Stewart J. Tepper, Merle L. Diamond, Joe Hirman, Roger Cady, Damian Fiore
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of NeurologyVol. 272(1)
Institutions
Missouri State University (US), Diamond Headache Clinic (US), Deerfield (United States) (US), New England Institute for Neurology and Headache (US), Lundbeck (United States) (US)